Mucopolysaccharidosis type I (MPS I). Multidiciplinary aspects and clinical guidelines

The existence of a specific enzyme replacement therapy for the treatment of Mucopolysaccharidosis type I has modified the natural course of the disease. Given the progressive nature and multisystem commitment, it is very important to coordinate interdisciplinary work, so as to provide comprehensive coverage and optimize results of all interventions made in patients. The content of this guide deals with current knowledge of Mucopolysaccharidosis (MPS) in general, and then more specifically in the subject matter of MPS I, with the contribution of specialists from each area, and from different institutions in the country. We will also find recommendations based on scientific evidence published in literatura.